Urolithiasis Management Devices Market
Urolithiasis Management Devices Market Forecasts to 2030 - Global Analysis By Product (Shock Wave Lithotripters and Ureterorenoscopes), End User (Clinics and Ambulatory Care Centers, Hospitals and Other End Users) and By Geography
|
Years Covered |
2021-2030 |
|
Estimated Year Value (2023) |
US $1.68 BN |
|
Projected Year Value (2030) |
US $2.69 BN |
|
CAGR (2023 - 2030) |
6.9% |
|
Regions Covered |
North America, Europe, Asia Pacific, South America, and Middle East & Africa |
|
Countries Covered |
US, Canada, Mexico, Germany, UK, Italy, France, Spain, Japan, China, India, Australia, New Zealand, South Korea, Rest of Asia Pacific, South America, Argentina, Brazil, Chile, Middle East & Africa, Saudi Arabia, UAE, Qatar, and South Africa |
|
Largest Market |
Asia Pacific |
|
Highest Growing Market |
North America |
According to Stratistics MRC, the Global Urolithiasis Management Devices Market is accounted for $1.68 billion in 2023 and is expected to reach $2.69 billion by 2030 growing at a CAGR of 6.9% during the forecast period. Urolithiasis refers to the development of stones in the urinary system. Urolithiasis Management Devices are specialized tools and equipment used in the diagnosis, treatment, and management of urinary stones, including kidney stones and stones within the urinary tract. These devices play a crucial role in minimally invasive treatments, reducing patient discomfort, shortening recovery times, and improving outcomes for individuals suffering from urolithiasis.
According to the European Association of Urology, the prevalence of urinary stones ranges from 1% up to 20%. Renal stones are substantially more common (>10%) in developed nations like Canada, Sweden, and the U.S.
Market Dynamics:
Driver:
Rising prevalence of urolithiasis
The escalating prevalence of urolithiasis, characterised by a rising incidence of kidney stones and urinary tract stones worldwide, serves as a significant driver in the Urolithiasis Management Devices Market. Lifestyle changes, dietary habits, and factors like inadequate hydration contribute to the increased occurrence of urolithiasis. This surge in cases necessitates effective management and treatment, fuelling the demand for urolithiasis management devices. As the prevalence continues to grow, there is a heightened need for advanced devices such as lithotripters, ureteroscopes, and stone retrieval tools, driving the market towards innovative solutions.
Restraint:
High treatment costs
The expenses associated with urolithiasis management, including surgical procedures, medical devices, and follow-up care, can be substantial. These high costs limit accessibility to advanced treatments and devices, particularly for patients with limited financial means or inadequate insurance coverage. The financial burden discourages some individuals from opting for advanced procedures, impacting their adoption and hindering market growth.
Opportunity:
Growing demand for minimally invasive procedures
Patients increasingly prefer minimally invasive treatments due to several advantages, including reduced post-operative pain, shorter hospital stays, quicker recovery times, and a lower risk of complications compared to traditional surgical methods. This trend has surged the demand for urolithiasis management devices that support minimally invasive techniques such as ureteroscopy, laser lithotripsy, and shockwave lithotripsy. Additionally, these devices enable precise targeting of stones while minimising trauma to surrounding tissues. Thus, there is an increasing demand for market growth.
Threat:
Risk of infection
Invasive procedures involving urolithiasis management devices, such as ureteral stents or lithotripsy tools, increase the susceptibility to infections. Improperly sterilised equipment, prolonged device placement, or repeated interventions may lead to urinary tract infections or systemic infections. These infections can cause complications, prolong hospital stays, and necessitate additional treatments, impacting patient health outcomes. As a result, it will hinder market demand.
Covid-19 Impact
The COVID-19 pandemic is causing disruptions in distribution channels and through its financial impact on firms and financial markets. Due to obstacles, various small hospitals and elderly housing units had to be temporarily closed. Additionally, there was a delay in the scheduling of appointments for outpatient clinics, which increased the demand for phone or virtual clinics. The absence of anaesthesia or procedural slots, in-hospital beds, and medical personnel resulted in a major treatment backlog, which had a negative impact on the worldwide urolithiasis management device market.
The ureterorenoscopes segment is expected to be the largest during the forecast period
The ureterorenoscopes segment is estimated to hold the largest share. Ureterorenoscopes consist of flexible or semi-rigid instruments equipped with miniature cameras and fibre-optic technology, allowing urologists to visualise and access stones in the ureter or kidney. They facilitate precise navigation through the urinary tract, enabling procedures like stone fragmentation, retrieval, or laser lithotripsy. Furthermore, ureterorenoscopes play a pivotal role in less invasive interventions, reducing patient discomfort, shortening recovery times, and contributing to effective stone management, thereby shaping the landscape of urolithiasis treatment.
The hospitals segment is expected to have the highest CAGR during the forecast period
The hospitals segment is anticipated to have lucrative growth during the forecast period. Hospitals serve as primary centres for the diagnosis, treatment, and management of urolithiasis cases. Within these facilities, various urolithiasis management devices are utilized, including lithotripters, ureteroscopes, stone retrieval tools, stents, and imaging modalities. Hospitals provide a comprehensive range of urological procedures and surgeries, offering both inpatient and outpatient services for urolithiasis patients. The segment encompasses diverse hospital settings, from large academic medical centres to smaller community hospitals, all contributing to the adoption and utilisation of urolithiasis management devices in the quest for effective patient care.
Region with largest share:
Asia Pacific commanded the largest market share during the extrapolated period due to the rising prevalence of urolithiasis, increasing healthcare expenditure, technological advancements, and a growing geriatric population. Moreover, improving healthcare infrastructure, greater accessibility to medical facilities, and expanding awareness about urolithiasis treatment options fuel the adoption of these devices. The Asia-Pacific market presents lucrative opportunities for manufacturers and providers aiming to cater to the evolving needs of urolithiasis patients in the region.
Region with highest CAGR:
North America is expected to witness profitable growth over the projection period due to preference for minimally invasive procedures, strong research and development activities, and favourable reimbursement policies. The region, encompassing the United States and Canada, boasts a robust healthcare infrastructure, high healthcare expenditures, and a significant focus on technological innovations in urology. Moreover, the presence of key market players, along with a growing emphasis on patient-centric care and technological advancements, positions North America as a leading hub for cutting-edge urolithiasis treatment solutions.
Key players in the market
Some of the key players in the Urolithiasis Management Devices Market include Olympus, Boston Scientific, Karl Storz, Siemens Medical Solutions, Richard Wolf, Cook Medical, Dornier, Elmed, MTS Medical, Direxgroup, Cybersonics, Allengers, BD, DirexGroup, CONMED Corporation, Potent Medical , and HealthTronics, Inc.
Key Developments:
In July 2022, Calyxo announced the successful closure of its Series C investment round, securing USD 32.7 million. Based in California, Calyxo has developed the CVAC Aspiration system, designed to eliminate kidney stones without the need for surgery, utilizing irrigation and aspiration methods.
In March 2022, The FDA recognized Applaud Medical's Acoustic Enhancer technology as a breakthrough product. It is designed to break down calcium-based urinary stones that are obstructing or pose a significant risk of future hindrance, provided they are between 6mm and 20 mm in diameter.
Products Covered:
• Shock Wave Lithotripters
• Ureterorenoscopes
End Users Covered:
• Clinics and Ambulatory Care Centers
• Hospitals
• Other End Users
Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Table of Contents
1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Product Analysis
3.7 End User Analysis
3.8 Emerging Markets
3.9 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Urolithiasis Management Devices Market, By Product
5.1 Introduction
5.2 Shock Wave Lithotripters
5.2.1 Intracorporeal
5.2.1.1 Ultrasound
5.2.1.2 Laser
5.2.1.3 Pneumatic
5.2.2 Extracorporea
5.3 Ureterorenoscopes
5.3.1 Rigid
5.3.2 Flexible
5.3.3 Semi Rigid
6 Global Urolithiasis Management Devices Market, By End User
6.1 Introduction
6.2 Clinics and Ambulatory Care Centers
6.3 Hospitals
6.4 Other End Users
7 Global Urolithiasis Management Devices Market, By Geography
7.1 Introduction
7.2 North America
7.2.1 US
7.2.2 Canada
7.2.3 Mexico
7.3 Europe
7.3.1 Germany
7.3.2 UK
7.3.3 Italy
7.3.4 France
7.3.5 Spain
7.3.6 Rest of Europe
7.4 Asia Pacific
7.4.1 Japan
7.4.2 China
7.4.3 India
7.4.4 Australia
7.4.5 New Zealand
7.4.6 South Korea
7.4.7 Rest of Asia Pacific
7.5 South America
7.5.1 Argentina
7.5.2 Brazil
7.5.3 Chile
7.5.4 Rest of South America
7.6 Middle East & Africa
7.6.1 Saudi Arabia
7.6.2 UAE
7.6.3 Qatar
7.6.4 South Africa
7.6.5 Rest of Middle East & Africa
8 Key Developments
8.1 Agreements, Partnerships, Collaborations and Joint Ventures
8.2 Acquisitions & Mergers
8.3 New Product Launch
8.4 Expansions
8.5 Other Key Strategies
9 Company Profiling
9.1 Olympus
9.2 Boston Scientific
9.3 Karl Storz
9.4 Siemens Medical Solutions
9.5 Richard Wolf
9.6 Cook Medical
9.7 Dornier
9.8 Elmed
9.9 MTS Medical
9.10 Direxgroup
9.11 Cybersonics
9.12 Allengers
9.13 BD
9.14 DirexGroup
9.15 CONMED Corporation
9.16 Potent Medical
9.17 EMS
9.18 HealthTronics, Inc
List of Tables
1 Global Urolithiasis Management Devices Market Outlook, By Region (2021-2030) ($MN)
2 Global Urolithiasis Management Devices Market Outlook, By Product (2021-2030) ($MN)
3 Global Urolithiasis Management Devices Market Outlook, By Shock Wave Lithotripters (2021-2030) ($MN)
4 Global Urolithiasis Management Devices Market Outlook, By Intracorporeal (2021-2030) ($MN)
5 Global Urolithiasis Management Devices Market Outlook, By Extracorporea (2021-2030) ($MN)
6 Global Urolithiasis Management Devices Market Outlook, By Ureterorenoscopes (2021-2030) ($MN)
7 Global Urolithiasis Management Devices Market Outlook, By Rigid (2021-2030) ($MN)
8 Global Urolithiasis Management Devices Market Outlook, By Flexible (2021-2030) ($MN)
9 Global Urolithiasis Management Devices Market Outlook, By Semi Rigid (2021-2030) ($MN)
10 Global Urolithiasis Management Devices Market Outlook, By End User (2021-2030) ($MN)
11 Global Urolithiasis Management Devices Market Outlook, By Clinics and Ambulatory Care Centers (2021-2030) ($MN)
12 Global Urolithiasis Management Devices Market Outlook, By Hospitals (2021-2030) ($MN)
13 Global Urolithiasis Management Devices Market Outlook, By Other End Users (2021-2030) ($MN)
14 North America Urolithiasis Management Devices Market Outlook, By Country (2021-2030) ($MN)
15 North America Urolithiasis Management Devices Market Outlook, By Product (2021-2030) ($MN)
16 North America Urolithiasis Management Devices Market Outlook, By Shock Wave Lithotripters (2021-2030) ($MN)
17 North America Urolithiasis Management Devices Market Outlook, By Intracorporeal (2021-2030) ($MN)
18 North America Urolithiasis Management Devices Market Outlook, By Extracorporea (2021-2030) ($MN)
19 North America Urolithiasis Management Devices Market Outlook, By Ureterorenoscopes (2021-2030) ($MN)
20 North America Urolithiasis Management Devices Market Outlook, By Rigid (2021-2030) ($MN)
21 North America Urolithiasis Management Devices Market Outlook, By Flexible (2021-2030) ($MN)
22 North America Urolithiasis Management Devices Market Outlook, By Semi Rigid (2021-2030) ($MN)
23 North America Urolithiasis Management Devices Market Outlook, By End User (2021-2030) ($MN)
24 North America Urolithiasis Management Devices Market Outlook, By Clinics and Ambulatory Care Centers (2021-2030) ($MN)
25 North America Urolithiasis Management Devices Market Outlook, By Hospitals (2021-2030) ($MN)
26 North America Urolithiasis Management Devices Market Outlook, By Other End Users (2021-2030) ($MN)
27 Europe Urolithiasis Management Devices Market Outlook, By Country (2021-2030) ($MN)
28 Europe Urolithiasis Management Devices Market Outlook, By Product (2021-2030) ($MN)
29 Europe Urolithiasis Management Devices Market Outlook, By Shock Wave Lithotripters (2021-2030) ($MN)
30 Europe Urolithiasis Management Devices Market Outlook, By Intracorporeal (2021-2030) ($MN)
31 Europe Urolithiasis Management Devices Market Outlook, By Extracorporea (2021-2030) ($MN)
32 Europe Urolithiasis Management Devices Market Outlook, By Ureterorenoscopes (2021-2030) ($MN)
33 Europe Urolithiasis Management Devices Market Outlook, By Rigid (2021-2030) ($MN)
34 Europe Urolithiasis Management Devices Market Outlook, By Flexible (2021-2030) ($MN)
35 Europe Urolithiasis Management Devices Market Outlook, By Semi Rigid (2021-2030) ($MN)
36 Europe Urolithiasis Management Devices Market Outlook, By End User (2021-2030) ($MN)
37 Europe Urolithiasis Management Devices Market Outlook, By Clinics and Ambulatory Care Centers (2021-2030) ($MN)
38 Europe Urolithiasis Management Devices Market Outlook, By Hospitals (2021-2030) ($MN)
39 Europe Urolithiasis Management Devices Market Outlook, By Other End Users (2021-2030) ($MN)
40 Asia Pacific Urolithiasis Management Devices Market Outlook, By Country (2021-2030) ($MN)
41 Asia Pacific Urolithiasis Management Devices Market Outlook, By Product (2021-2030) ($MN)
42 Asia Pacific Urolithiasis Management Devices Market Outlook, By Shock Wave Lithotripters (2021-2030) ($MN)
43 Asia Pacific Urolithiasis Management Devices Market Outlook, By Intracorporeal (2021-2030) ($MN)
44 Asia Pacific Urolithiasis Management Devices Market Outlook, By Extracorporea (2021-2030) ($MN)
45 Asia Pacific Urolithiasis Management Devices Market Outlook, By Ureterorenoscopes (2021-2030) ($MN)
46 Asia Pacific Urolithiasis Management Devices Market Outlook, By Rigid (2021-2030) ($MN)
47 Asia Pacific Urolithiasis Management Devices Market Outlook, By Flexible (2021-2030) ($MN)
48 Asia Pacific Urolithiasis Management Devices Market Outlook, By Semi Rigid (2021-2030) ($MN)
49 Asia Pacific Urolithiasis Management Devices Market Outlook, By End User (2021-2030) ($MN)
50 Asia Pacific Urolithiasis Management Devices Market Outlook, By Clinics and Ambulatory Care Centers (2021-2030) ($MN)
51 Asia Pacific Urolithiasis Management Devices Market Outlook, By Hospitals (2021-2030) ($MN)
52 Asia Pacific Urolithiasis Management Devices Market Outlook, By Other End Users (2021-2030) ($MN)
53 South America Urolithiasis Management Devices Market Outlook, By Country (2021-2030) ($MN)
54 South America Urolithiasis Management Devices Market Outlook, By Product (2021-2030) ($MN)
55 South America Urolithiasis Management Devices Market Outlook, By Shock Wave Lithotripters (2021-2030) ($MN)
56 South America Urolithiasis Management Devices Market Outlook, By Intracorporeal (2021-2030) ($MN)
57 South America Urolithiasis Management Devices Market Outlook, By Extracorporea (2021-2030) ($MN)
58 South America Urolithiasis Management Devices Market Outlook, By Ureterorenoscopes (2021-2030) ($MN)
59 South America Urolithiasis Management Devices Market Outlook, By Rigid (2021-2030) ($MN)
60 South America Urolithiasis Management Devices Market Outlook, By Flexible (2021-2030) ($MN)
61 South America Urolithiasis Management Devices Market Outlook, By Semi Rigid (2021-2030) ($MN)
62 South America Urolithiasis Management Devices Market Outlook, By End User (2021-2030) ($MN)
63 South America Urolithiasis Management Devices Market Outlook, By Clinics and Ambulatory Care Centers (2021-2030) ($MN)
64 South America Urolithiasis Management Devices Market Outlook, By Hospitals (2021-2030) ($MN)
65 South America Urolithiasis Management Devices Market Outlook, By Other End Users (2021-2030) ($MN)
66 Middle East & Africa Urolithiasis Management Devices Market Outlook, By Country (2021-2030) ($MN)
67 Middle East & Africa Urolithiasis Management Devices Market Outlook, By Product (2021-2030) ($MN)
68 Middle East & Africa Urolithiasis Management Devices Market Outlook, By Shock Wave Lithotripters (2021-2030) ($MN)
69 Middle East & Africa Urolithiasis Management Devices Market Outlook, By Intracorporeal (2021-2030) ($MN)
70 Middle East & Africa Urolithiasis Management Devices Market Outlook, By Extracorporea (2021-2030) ($MN)
71 Middle East & Africa Urolithiasis Management Devices Market Outlook, By Ureterorenoscopes (2021-2030) ($MN)
72 Middle East & Africa Urolithiasis Management Devices Market Outlook, By Rigid (2021-2030) ($MN)
73 Middle East & Africa Urolithiasis Management Devices Market Outlook, By Flexible (2021-2030) ($MN)
74 Middle East & Africa Urolithiasis Management Devices Market Outlook, By Semi Rigid (2021-2030) ($MN)
75 Middle East & Africa Urolithiasis Management Devices Market Outlook, By End User (2021-2030) ($MN)
76 Middle East & Africa Urolithiasis Management Devices Market Outlook, By Clinics and Ambulatory Care Centers (2021-2030) ($MN)
77 Middle East & Africa Urolithiasis Management Devices Market Outlook, By Hospitals (2021-2030) ($MN)
78 Middle East & Africa Urolithiasis Management Devices Market Outlook, By Other End Users (2021-2030) ($MN)
List of Figures
RESEARCH METHODOLOGY
We at ‘Stratistics’ opt for an extensive research approach which involves data mining, data validation, and data analysis. The various research sources include in-house repository, secondary research, competitor’s sources, social media research, client internal data, and primary research.
Our team of analysts prefers the most reliable and authenticated data sources in order to perform the comprehensive literature search. With access to most of the authenticated data bases our team highly considers the best mix of information through various sources to obtain extensive and accurate analysis.
Each report takes an average time of a month and a team of 4 industry analysts. The time may vary depending on the scope and data availability of the desired market report. The various parameters used in the market assessment are standardized in order to enhance the data accuracy.
Data Mining
The data is collected from several authenticated, reliable, paid and unpaid sources and is filtered depending on the scope & objective of the research. Our reports repository acts as an added advantage in this procedure. Data gathering from the raw material suppliers, distributors and the manufacturers is performed on a regular basis, this helps in the comprehensive understanding of the products value chain. Apart from the above mentioned sources the data is also collected from the industry consultants to ensure the objective of the study is in the right direction.
Market trends such as technological advancements, regulatory affairs, market dynamics (Drivers, Restraints, Opportunities and Challenges) are obtained from scientific journals, market related national & international associations and organizations.
Data Analysis
From the data that is collected depending on the scope & objective of the research the data is subjected for the analysis. The critical steps that we follow for the data analysis include:
- Product Lifecycle Analysis
- Competitor analysis
- Risk analysis
- Porters Analysis
- PESTEL Analysis
- SWOT Analysis
The data engineering is performed by the core industry experts considering both the Marketing Mix Modeling and the Demand Forecasting. The marketing mix modeling makes use of multiple-regression techniques to predict the optimal mix of marketing variables. Regression factor is based on a number of variables and how they relate to an outcome such as sales or profits.
Data Validation
The data validation is performed by the exhaustive primary research from the expert interviews. This includes telephonic interviews, focus groups, face to face interviews, and questionnaires to validate our research from all aspects. The industry experts we approach come from the leading firms, involved in the supply chain ranging from the suppliers, distributors to the manufacturers and consumers so as to ensure an unbiased analysis.
We are in touch with more than 15,000 industry experts with the right mix of consultants, CEO's, presidents, vice presidents, managers, experts from both supply side and demand side, executives and so on.
The data validation involves the primary research from the industry experts belonging to:
- Leading Companies
- Suppliers & Distributors
- Manufacturers
- Consumers
- Industry/Strategic Consultants
Apart from the data validation the primary research also helps in performing the fill gap research, i.e. providing solutions for the unmet needs of the research which helps in enhancing the reports quality.
For more details about research methodology, kindly write to us at info@strategymrc.com
Frequently Asked Questions
In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.
Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.
All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
We have 3 different licensing options available in electronic format.
- Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
- 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
- Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.
All our reports are typically be emailed to you as an attachment.
To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.
We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.
Request Customization
We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.
WHY CHOOSE US ?
Assured Quality
Best in class reports with high standard of research integrity
24X7 Research Support
Continuous support to ensure the best customer experience.
Free Customization
Adding more values to your product of interest.
Safe & Secure Access
Providing a secured environment for all online transactions.
Trusted by 600+ Brands
Serving the most reputed brands across the world.
